文献速递消化道肿瘤与早癌消化内镜

通过机器学习构建外泌体非编码RNA特征用于胃癌患者无创早期检测:一项多队列研究

Construction of exosome non-coding RNA feature for non-invasive, early detection of gastric cancer patients by machine learning: a multi-cohort study.
PubMed 文献 · Gut · 2025-05-07

本研究旨在构建血清外泌体非编码RNA特征以提升胃癌诊断。对37例胃癌患者和20例健康供者血清外泌体行RNA测序,鉴定出182个候选标志物,其中31个经qRT-PCR验证。基于518例胃癌患者和460例健康供者构建LASSO-logistic回归联合诊断模型,由4个长链非编码RNA组成的cd-score在训练、测试和外部验证队列中区分胃癌与健康供者的AUC分别为0.959、0.942和0.949,并优于癌胚抗原、CA19-9和CA72-4。

要点

  • 血清外泌体ncRNA特征cd-score在训练、测试和外部验证队列区分胃癌与健康供者的AUC分别为0.959、0.942和0.949。
  • cd-score可有效识别胃肠肿瘤标志物阴性的胃癌患者及早期胃癌患者。
  • 敲低DGCR9可抑制胃癌肿瘤生长。

核心结论

  • 所提出的血清外泌体非编码RNA特征为提升胃癌早期诊断提供了一种有前景的液体活检方法。

研究设计与样本

  • 对37例胃癌患者和20例健康供者的血清外泌体行RNA测序,并在血清外泌体和组织中用qRT-PCR验证候选标志物。
  • 基于518例胃癌患者和460例健康供者,采用LASSO-logistic回归构建联合诊断模型,并通过受试者工作特征曲线评估诊断性能。

主要发现

  • RNA测序鉴定出182个胃癌候选标志物,其中31个经qRT-PCR验证为潜在标志物。
  • 由4个长链非编码RNA(RP11.443C10.1、CTD-2339L15.3、LINC00567和DiGeorge综合征关键区域基因DGCR9)表达水平得出的联合诊断评分cd-score,在训练、测试和外部验证队列中区分胃癌患者与健康供者的AUC分别为0.959、0.942和0.949。
  • cd-score在区分胃癌患者与健康供者方面优于癌胚抗原、碳水化合物抗原19-9(CA19-9)和CA72-4。
  • cd-score可有效识别胃肠肿瘤标志物阴性的胃癌患者和早期胃癌患者。
  • 分子生物学实验显示,敲低DGCR9可抑制胃癌肿瘤生长。

关键数值与推荐

  • 训练队列中cd-score区分胃癌患者与健康供者的AUC为0.959。
  • 测试队列中cd-score区分胃癌患者与健康供者的AUC为0.942。
  • 外部验证队列中cd-score区分胃癌患者与健康供者的AUC为0.949。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVE: Gastric cancer (GC) remains a prevalent and preventable disease, yet accurate early diagnostic methods are lacking. Exosome non-coding RNAs (ncRNAs), a type of liquid biopsy, have emerged as promising diagnostic biomarkers for various tumours. This study aimed to identify a serum exosome ncRNA feature for enhancing GC diagnosis. DESIGNS: Serum exosomes from patients with GC (n=37) and healthy donors (n=20) were characterised using RNA sequencing, and potential biomarkers for GC were validated through quantitative reverse transcription PCR (qRT-PCR) in both serum exosomes and tissues. A combined diagnostic model was developed using LASSO-logistic regression based on a cohort of 518 GC patients and 460 healthy donors, and its diagnostic performance was evaluated via receiver operating characteristic curves. RESULTS: RNA sequencing identified 182 candidate biomarkers for GC, of which 31 were validated as potential biomarkers by qRT-PCR. The combined diagnostic score (cd-score), derived from the expression levels of four long ncRNAs (RP11.443C10.1, CTD-2339L15.3, LINC00567 and DiGeorge syndrome critical region gene (DGCR9)), was found to surpass commonly used biomarkers, such as carcinoembryonic antigen, carbohydrate antigen 19-9 (CA19-9) and CA72-4, in distinguishing GC patients from healthy donors across training, testing and external validation cohorts, with AUC values of 0.959, 0.942 and 0.949, respectively. Additionally, the cd-score could effectively identify GC patients with negative gastrointestinal tumour biomarkers and those in early-stage. Furthermore, molecular biological assays revealed that knockdown of DGCR9 inhibited GC tumour growth. CONCLUSIONS: Our proposed serum exosome ncRNA feature provides a promising liquid biopsy approach for enhancing the early diagnosis of GC.

来源:Gut,查看原文。版权归原作者所有。

引用

  1. Cai ZR, Zheng YQ, Hu Y, et al. Construction of exosome non-coding RNA feature for non-invasive, early detection of gastric cancer patients by machine learning: a multi-cohort study. Gut. 2025. PMID: 39753334. doi:10.1136/gutjnl-2024-333522

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。